Corporate News tagged:
3D Cell Culture (2)
Nov 04, 2013
Reinnervate Ltd partners with Oncotest and SBH Sciences on introductory services for screening novel anti-cancer drugs using 3D tumour cell culture
3D cell culture company Reinnervate Ltd today announced partnerships with two oncology-focussed CRO’s to offer 3D tumour cell screening services.
Sep 19, 2013
Reinnervate Ltd and Roslin Cellab to partner around 3D stem cell printing products and technologies
Specialist 3D cell culture company Reinnervate Ltd today announced that it is entering into a collaboration with leading stem cell company Roslin Cellab to develop 3D stem cell printing products and services using Alvetex® technology.
Aug 22, 2013
Prof. Stefan Przyborski to participate at the XCellR8 Human Primary Cell Culture course, 7 November 2013
Read the announcement that Reinnervate’s CSO, Professor Stefan Przyborski, will be participating at the XCellR8 Human Primary Cell Culture course.
Jul 31, 2013
Alvetex 3D cell culture scaffolds chosen by investigators at Massachusetts General Hospital for study of bone loss during space flight
Alvetex Scaffold system has been chosen by a group at Massachusetts General Hospital for the first ever 3D osteocytic cell culture experiments in microgravity
Jan 07, 2013
3D cell culture firm Reinnervate and specialist Oncology CRO Oncotest GmbH enter collaboration agreement
Learn more about how Oncotest is integrating Alvetex Scaffold 3d cell culture technology into its cancer research screening services.
Dec 14, 2012
3D cell culture firm Reinnervate announces the release of Alvetex®Scaffold 96 well plates for high throughput 3D cell-based assays
Market leading 3D cell culture company, Reinnervate Ltd, today announced that it has launched and commenced shipments of Alvetex® Scaffold 96 well plates to customers.
Jul 09, 2012
Medicyte GmbH and Reinnervate Ltd to collaborate on development of next generation predictive 3D cell toxicity assays
Read about a new product collaboration between two market leading companies in the field of cell based assays and predictive toxicology.
Jun 27, 2012
Top award for 3D cell culture pioneer, Stefan Przyborski, of Reinnervate Ltd
Prof Stefan Przyborski, CSO and founder of Reinnervate Ltd has been recognised with a top award from the Royal Society of Chemistry.
Jun 17, 2012
Reinnervate and Tecan to develop automated 3D cell culture solutions for improved cellular assays
Reinnervate Ltd and Tecan Trading AG, have signed a co-marketing agreement to develop a range of automated solutions for 3D cell culture, find out more.
Apr 30, 2012
Reinnervate Ltd and Roslin Cellab announce plans to collaborate
Reinnervate Ltd and Roslin Cellab, two leading UK companies in the fields of 3D cell culture and stem cell biology, today announced that they will join forces to develop protocols for the three dimensional growth of human Embryonic Stem Cells (hESCs).
Mar 30, 2012
Reinnervate Ltd announce Kirkstall Ltd collaboration
Reinnervate (inventors of Alvetex® Scaffold) and Kirkstall (developers of the Quasi-Vivo® system) today announced that they will collaborate to bring next generation three dimensional (3D) cell culture products to market in 2012.
Nov 16, 2011
Reinnervate and Mirus Bio announce collaboration with the launch of the new 3D Transfection System for the transfection of cells cultured in Alvetex®
Read today's announcement that Reinnervate and Mirus Bio have entered into a commercial agreement to launch a new range of 3d cell culture products.
Jun 27, 2011
Alvetex® voted one of most technologically significant new research products by R&D magazine
Reinnervate, an innovative life sciences company driving the adoption of routine 3D cell culture, is delighted to announce that Alvetex®, its breakthrough 3D cell culture technology, is among the winners of the prestigious 49th Annual R&D 100 Awards.
Dec 06, 2010
Alvetex® named in the top ten life science innovations of 2010 by The Scientist magazine
Reinnervate, an innovative life sciences company driving the adoption of routine 3D cell culture, is proud to announce that Alvetex®, its breakthrough 3D cell culture technology, is among the winners of The Scientist magazine’s“Top 10 Life Science Innovations of 2010”.
Nov 22, 2010
Reinnervate launches Alvetex®, a breakthrough product for enabling routine 3D cell culture
Reinnervate, is very pleased to announce today the first commercial launch of Alvetex®, its breakthrough 3D cell culture technology. find out more.
Nov 17, 2010
Reinnervate completes expansion into new purpose-built facility at NETPark
Reinnervate, an innovative life sciences company driving the adoption of routine 3D cell culture, today announced its expansion into a new purpose-built research and production facility at NETPark near Sedgefield, UK.
Sep 28, 2010
Reinnervate’s ec23® shown to enhance neuronal differentiation of human fetal neuroprogenitors and human embryonic stem cells
Read more about Reinnervate’s ec23 and its ability to enhance neuronal differentiation as demonstrated in a paper published in Neuroscience Methods.
Sep 28, 2010
Reinnervate wins Chemistry Innovation / EPSRC Industrial CASE Award to fund development of Alvetex® for the 3D culture of liver cells
Reinnervate has been granted a Chemistry Innovation Knowledge Transfer Network / EPSRC Industrial CASE Award to fund the development of a next-generation Alvetex® scaffold optimised for 3D hepatocyte culture.
Sep 14, 2010
Reinnervate has been accepted as a new member of the In Vitro Testing Industrial Platform (IVTIP)
Reinnervate has been accepted into the In Vitro Testing Industrial Platform, advising European bodies on research projects in in vitro testing.
May 27, 2010
Reinnervate secures £1.8 million of investment to support commercialisation of Alvetex
Reinnervate has successfully raised £1.8 million in new equity funding to complete the development of its Alvetex® 3D cell culture platform.